Retraction
Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
Paper Information
Record ID:
25014
Publication Date:
June 23, 2014
Retraction Date:
January 11, 2021
(4.9 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.vaccine.2020.12.068Additional Notes:
Shin Hee Kim has ORI finding of misconduct; see also: https://ori.hhs.gov/content/case-summary-kim-shin-hee;
Citations (34)
34
Total Citations3
Post-Retraction(8.8%)
31
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
652
Days since retraction (latest)
Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo
Xiaolong Lu, Tiansong Zhan, Kaituo Liu et al. (11 authors)
Viruses
Open Access
Published: Oct 2022
4 citations
4 citations
652 days after retraction
Newcastle Disease Virus
Ian H. Brown, Peter Cargill, R M Woodland et al. (4 authors)
Unknown Journal
Published: May 2021
5 citations
5 citations
116 days after retraction
Recovery of Recombinant Avian Paramyxovirus Type-3 Strain Wisconsin by Reverse Genetics and Its Evaluation as a Vaccine Vector for Chickens
Mohamed A. Elbehairy, Sunil K. Khattar, Siba K. Samal
Viruses
Open Access
Published: Feb 2021
4 citations
4 citations
39 days after retraction
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
Sophia M. Vrba, Natalie M. Kirk, Morgan Brisse et al. (5 authors)
Vaccines
Open Access
Published: Nov 2020
69 citations
69 citations
59 days before retraction
Retraction notice: Role of C596 in the C-terminal extension of the haemagglutinin–neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus
The Microbiology Society
Journal of General Virology
Open Access
Published: Sep 2020
1 citation
1 citation
132 days before retraction
Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses
Tong Wang, Fanhua Wei, Jinhua Liu
Viruses
Open Access
Published: Aug 2020
27 citations
27 citations
157 days before retraction
Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
Edris Shirvani, Anandan Paldurai, Berin P. Varghese et al. (4 authors)
Frontiers in Microbiology
Open Access
Published: Jun 2020
14 citations
14 citations
220 days before retraction
Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector
Magdalena Murr, Christian Grund, Angele Breithaupt et al. (5 authors)
Avian Diseases
Published: May 2020
9 citations
9 citations
238 days before retraction
Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels
Magdalena Murr, Axel Karger, Constanze Steglich et al. (5 authors)
Journal of General Virology
Open Access
Published: Mar 2020
6 citations
6 citations
292 days before retraction
A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
Edris Shirvani, Berin P. Varghese, Anandan Paldurai et al. (4 authors)
Scientific Reports
Open Access
Published: Feb 2020
14 citations
14 citations
336 days before retraction
Attenuate Newcastle disease virus by codon modification of the glycoproteins and phosphoprotein genes
Weijia Wang, Xing Cheng, Paul J. Buske et al. (5 authors)
Virology
Open Access
Published: Jan 2019
10 citations
10 citations
737 days before retraction
Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
Michelle Meyer, Asuka Yoshida, Palaniappan Ramanathan et al. (8 authors)
Cell Reports
Open Access
Published: Aug 2018
14 citations
14 citations
894 days before retraction
Prime-boost vaccination strategy against avian influenza and Newcastle disease viruses reduces shedding of the challenge viruses
Nermeen M. Ismail, Ayman H. El‐Deeb, Mohamed M. Emara et al. (6 authors)
VirusDisease
Open Access
Published: Jun 2018
6 citations
6 citations
930 days before retraction
Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
Vinoth K. Manoharan, Sunil K. Khattar, Celia C. LaBranche et al. (5 authors)
Scientific Reports
Open Access
Published: Jun 2018
10 citations
10 citations
950 days before retraction
Immunization of Domestic Ducks with Live Nonpathogenic H5N3 Influenza Virus Prevents Shedding and Transmission of Highly Pathogenic H5N1 Virus to Chickens
Alexandra Gambaryan, Ilya Gordeychuk, Elizaveta Boravleva et al. (8 authors)
Viruses
Open Access
Published: Mar 2018
2 citations
2 citations
1017 days before retraction
Parainfluenza virus 5–vectored vaccines against human and animal infectious diseases
Zhenhai Chen
Reviews in Medical Virology
Open Access
Published: Jan 2018
25 citations
25 citations
1102 days before retraction
Reverse Genetics for Newcastle Disease Virus as a Vaccine Vector
Shin‐Hee Kim, Siba K. Samal
Current Protocols in Microbiology
Published: Jan 2018
17 citations
17 citations
1106 days before retraction
Live poultry vaccines against highly pathogenic avian influenza viruses
Elizaveta Boravleva, Alexandra Gambaryan
Microbiology Independent Research Journal (MIR Journal)
Open Access
Published: Jan 2018
3 citations
3 citations
1106 days before retraction
Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus
Jingjiao Ma, Jinhwa Lee, Haixia Liu et al. (14 authors)
npj Vaccines
Open Access
Published: Oct 2017
32 citations
32 citations
1169 days before retraction
Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses
Shin‐Hee Kim, Siba K. Samal
Vaccine
Published: Jun 2017
20 citations
20 citations
1293 days before retraction
Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses
Darrell R. Kapczynski, Mary J. Pantin‐Jackwood, Erica Spackman et al. (6 authors)
Vaccine
Open Access
Published: Apr 2017
41 citations
41 citations
1355 days before retraction
Avian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene
Asuka Yoshida, Siba K. Samal
Frontiers in Microbiology
Open Access
Published: Apr 2017
21 citations
21 citations
1362 days before retraction
Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge
Ran Zhao, Junfeng Sun, Tianming Qi et al. (7 authors)
Vaccine
Published: Mar 2017
40 citations
40 citations
1391 days before retraction
A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus
Shin‐Hee Kim, Anandan Paldurai, Siba K. Samal
Virology
Open Access
Published: Jan 2017
38 citations
38 citations
1452 days before retraction
Newcastle disease vaccines—A solved problem or a continuous challenge?
Kiril M. Dimitrov, Claudio L. Afonso, Qingzhong Yu et al. (4 authors)
Veterinary Microbiology
Open Access
Published: Dec 2016
333 citations
333 citations
1487 days before retraction
Recombinant viral-vectored vaccines for the control of avian influenza in poultry
David L. Suarez, Mary J. Pantin‐Jackwood
Veterinary Microbiology
Published: Nov 2016
59 citations
59 citations
1509 days before retraction
Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA)
Jin-Yong Noh, Jae-Keun Park, Dong‐Hun Lee et al. (10 authors)
PLoS ONE
Open Access
Published: Sep 2016
20 citations
20 citations
1580 days before retraction
Viral vector-based influenza vaccines
Rory D. de Vries, Guus F. Rimmelzwaan
Human Vaccines & Immunotherapeutics
Open Access
Published: Jul 2016
53 citations
53 citations
1631 days before retraction
Newcastle Disease Virus as a Vaccine Vector for Development of Human and Veterinary Vaccines
Shin‐Hee Kim, Siba K. Samal
Viruses
Open Access
Published: Jul 2016
120 citations
120 citations
1652 days before retraction
Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice
Xinxin Chen, Jifei Yang, Yanhong Ji et al. (8 authors)
Virologica Sinica
Open Access
Published: Mar 2016
25 citations
25 citations
1767 days before retraction
Avian Influenza Virus and DIVA Strategies
Noor Haliza Hasan, Jagoda Ignjatovic, Anne E. Peaston et al. (4 authors)
Viral Immunology
Published: Feb 2016
22 citations
22 citations
1785 days before retraction
Recombinant Newcastle Disease Virus-Vectored Vaccines Against Human and Animal Infectious Diseases
Zhiqiang Duan, Houqiang Xu, Xinqin Ji et al. (4 authors)
Future Microbiology
Published: Aug 2015
27 citations
27 citations
1990 days before retraction
The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa
Bitrus Yakubu, J Nok Andrew, Olajide A. Owolodun et al. (5 authors)
Biotechnology and Molecular Biology Reviews
Open Access
Published: Jul 2015
2 citations
2 citations
1992 days before retraction
Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings
Jianzhong Wang, Yanlong Cong, Renfu Yin et al. (14 authors)
Virus Research
Open Access
Published: Apr 2015
25 citations
25 citations
2098 days before retraction
Quick Stats
Total Citations:
34
Years Since Retraction:
4.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025